-
in the AR-DMRI Department of Diabetes Immunology. The research is highly translational and primarily focused on human type 1 diabetes. The major ongoing projects are investigating miRNA biomarkers
-
. The project involves both in vitro and in vivo studies to uncover the molecular and cellular mechanisms driving cancer-associated immunosuppression using mouse and human solid tumor models. Additionally
-
PMC5706612). As a successful candidate you will: · Have experience and knowledge of human and murine immunology, selection tools for predicting immunologic epitopes complementing virology skills
-
highly motivated postdoctoral fellow to study transcriptional regulation and RNA metabolism in normal development and human diseases, such as neurological disorder, immunology, and cancer. In particular
-
evolution. Our work builds on experience developing pangenome graph construction and analysis tools (PGGB, ODGI, IMPG) and contributions to the Telomere-to-Telomere Consortium and Human Pangenome Reference
-
should include: A Ph.D. degree in life or biomedical sciences, or related discipline is required. Experience with mouse (PDX, humanized) models. Ability to effectively lead other scientists in a
-
basis of hematologic malignancies. Work with mouse models, human tumor samples, and high-throughput technologies (e.g., next-generation sequencing, flow cytometry, and immunohistochemistry). Analyze
-
/epitranscriptomics (RNA modifications) and RNA-based therapeutics. Our research involves experiments with RNA Biology, RNA modifications/editing, mRNA-based therapeutics, primary human cancer cells, cancer and stem
-
, animal models, and human tissues, conduct bioinformatics analysis for high-throughput sequencing data, and report research findings in scientific publications and oral/poster presentations at select
-
, or immunotherapy. · Ability to work in a fast-paced research environment and manage multiple projects and collaborations. · Previous experience working with human specimens and developing novel